See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

SDF-1 Plasmid for Treatment of Critical Limb Ischemia

Presenter: David Paul Slovut

January 22, 2013

Presentation Cell Therapy 2013

IK 5001 - A Novel Approach to Myocardial Remodeling

Presenter: David F. Kong

January 22, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

Multimodality Imaging: Enhancing Outcomes with Available Technology

Presenter: Amish Raval

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation Cell Therapy 2013

STEM-AMI trial: cMRI and other observations at 3 years

Presenter: Giulio Pompilio

January 22, 2013

Presentation Cell Therapy 2013

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

Presenter: Marc S. Penn

January 22, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Presenter: Emerson C.Perin

January 22, 2013

Advertisement

Slides

SDF-1 Plasmid for Treatment of Critical Limb Ischemia

IK 5001 - A Novel Approach to Myocardial Remodeling

BMAC for CLI: Status of a Phase 3 Trial

Multimodality Imaging: Enhancing Outcomes with Available Technology

IMPACT Clinical Trial Program: Findings and Strategic Update

EXCELLENT Trial Design

STEM-AMI trial: cMRI and other observations at 3 years

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content